第一个三个月的肝酶升高与妊娠糖尿病有关:一项前性队列研究
Lingling Cui1, Xiaoli Yang1, Zhiqian Li1
1College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Diabetes/metabolism research and reviews
|March 28, 2024
概括
妊娠早期肝酶升高,特别是胺转移酶 (GGT),性酸酶和酸氨转移酶,显著预测妊娠糖尿病 (GDM) 风险.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 关于单个肝酶对妊娠糖尿病 (GDM) 的预测价值存在不一致的发现.
- 怀孕早期的肝酶水平可能有助于了解GDM风险.
- 确定可靠的早期预测因素对于GDM管理至关重要.
研究的目的:
- 为了研究早期怀孕肝酶与GDM风险之间的关联.
- 独立排名导致GDM发展的风险因素.
主要方法:
- 对1295名孕妇进行前性队列研究.
- 在怀孕早期测量肝酶,并在怀孕中期评估GDM.
- 使用后勤回归,受限立方线和反向传播的人工神经网络分析.
主要成果:
- 与没有GDM的女性相比,患有GDM的女性的肝酶水平显著更高 (p <0.05).
- 肝酶的最高四分位数与增加的GDM风险相关 (ORs2.76-8.11,p <0.05).
- 玛-氨基转移酶 (GGT) 成为最重要的预测因子,占GDM风险预测的20.8%.
结论:
- 肝酶的升高,包括GGT,性酸酶和酸氨基转移酶,是GDM的显著预测因素.
- 这些肝酶作为GDM的重要独立风险因素.
- 怀孕早期的肝酶查可能有助于识别患有GDM高风险的女性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196


